Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Venture Partners (NVP) is a global venture capital firm that specializes in corporate venturing and technology spin-outs. Founded in 2001 to acquire the Lucent New Ventures Group from Lucent Technologies (Bell Labs), the firm has a long history of identifying and commercializing breakthrough technologies from corporate research laboratories. While NVP invests across various technology sectors, it has a significant presence in the life sciences and healthcare industries, having helped launch and fund companies such as Aerie Pharmaceuticals and Intelligene. The firm operates by partnering with major corporations like Philips and Lucent to create independent, venture-backed startups based on innovations that fall outside the parent company's core business strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Venture Partners.